Alpha Tau Medical of Tel Aviv raised $29 million from Shavit Capital, OurCrowd and Medison Ventures, the venture capital arm of Israeli healthcare company Medison Pharma, as well as private equity investors to further develop its solid-tumor treatment technology using alpha radiation.

Read more on Israel21c here.